Cargando…
PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428707/ http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7 |
_version_ | 1785090533525291008 |
---|---|
author | Risitano, Antonio Maria Araten, David J Kuter, David Patel, Bhumika J de Latour, Régis Peffault Dahlke, Marion Garito, Tania LI, Shujie Maitra, Samopriyo Kulasekararaj, Austin |
author_facet | Risitano, Antonio Maria Araten, David J Kuter, David Patel, Bhumika J de Latour, Régis Peffault Dahlke, Marion Garito, Tania LI, Shujie Maitra, Samopriyo Kulasekararaj, Austin |
author_sort | Risitano, Antonio Maria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104287072023-08-17 PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL Risitano, Antonio Maria Araten, David J Kuter, David Patel, Bhumika J de Latour, Régis Peffault Dahlke, Marion Garito, Tania LI, Shujie Maitra, Samopriyo Kulasekararaj, Austin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428707/ http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Risitano, Antonio Maria Araten, David J Kuter, David Patel, Bhumika J de Latour, Régis Peffault Dahlke, Marion Garito, Tania LI, Shujie Maitra, Samopriyo Kulasekararaj, Austin PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title | PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title_full | PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title_fullStr | PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title_full_unstemmed | PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title_short | PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL |
title_sort | pb2063: appulse-pnh: a phase iiib trial to evaluate the efficacy and safety of switching to iptacopan in patients with paroxysmal nocturnal hemoglobinuria (pnh) on anti-c5 therapy with hemoglobin >10g/dl |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428707/ http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7 |
work_keys_str_mv | AT risitanoantoniomaria pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT aratendavidj pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT kuterdavid pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT patelbhumikaj pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT delatourregispeffault pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT dahlkemarion pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT garitotania pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT lishujie pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT maitrasamopriyo pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl AT kulasekararajaustin pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl |